Search

Search Results

• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3796

  PDF: 552

• Septic arthritis: what is the role for the rheumatologist?

  F. Schiavon, M. Favero, V. Carraro, L. Riato

  1-5

  https://doi.org/10.4081/reumatismo.2008.1

  1230

  PDF: 1482

• Hyper-IgD syndrome and hereditary periodic fever syndromes

  R. Scolozzi, A. Boccafogli, L. Vicentini

  147-155

  https://doi.org/10.4081/reumatismo.2004.147

  1193

  PDF: 3336

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  https://doi.org/10.4081/reumatismo.2010.12

  1516

  PDF: 1234
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1235

  937

  PDF: 616